Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
04/2008
04/02/2008CN100378107C Oxazolo-and-furopyrimidines and their use as medicaments against tumors
04/02/2008CN100378104C 1H-pyranyl[3,4d][1,2,3] tri-azonyl-4-ketonic compound, synthetic method and use
04/01/2008US7351837 Thermally cleavable surfactants without deprotonation
04/01/2008US7351830 Formed by selective phosphorylation of phenpanstatin with tetrabutylammonium dihydrogen phosphate and dicyclohexylcarbodiimide in pyridine followed by cation exchange; cancer cell inhibitors
04/01/2008US7351829 Compounds on the basis of 2- and 4-chromenylidene-merocyanines respectively, and their use
04/01/2008US7351735 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias
04/01/2008US7351714 viral infections; lung tumor and gastric cancer; 7-2-(2-aminophenyldithio)phenyliminomethylcamptothecin
04/01/2008US7351700 4-(2-Hexylsulfanyl-6-methyl-pyrimidin-4-ylmethyl)-morpholine; antidepressant, anxiolytic agent, cognition activator; epilepsy, schizophrenia, spasticity and skeletal muscle rigidity, spinal cord injury, multiple sclerosis, amyotrophic lateral sclerosis, neuropathic pain
04/01/2008US7351461 Thermal stability; coloring many different kinds of polymers; eyewear, medical device, drug packaging, automotive part, a telecommunication accessory, a computer, a consumer electronic, or a construction material
04/01/2008CA2432578C Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
03/2008
03/27/2008WO2008035377A2 Novel intermediates for the preparation of camptothecin analogues
03/27/2008WO2008035195A1 Benzimidazole derivatives as selective acid pump inhibitors
03/27/2008WO2008034781A1 Cysteine protease inhibitor salt
03/27/2008WO2007117381A9 2 -aminopyridine analogs as glucokinase activators
03/27/2008WO2007109334B1 Sip receptor modulating compounds and use thereof
03/27/2008US20080076792 Heterobifunctional Polymeric Bioconjugates
03/27/2008US20080076791 5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin and its preparation and use for the treatment of cancer
03/27/2008US20080076790 Anticancer agents; 5(R)-(2''-hydroxyethoxy)-20(S)-camptothecin; X-ray powder diffraction
03/27/2008US20080076758 1S,4S)-2-((2-(1H-indazol-4-yl)-4- morpholinothieno[3,2-d]pyrirnidin-6- yl)methyl)-5-methylsulfonyl-2,5- diaza-bicyclo[2.2.1]heptane; 2-(6-fluoropyridin-3-yl)-6-((4- methylsulfonylpiperazin-1-yl)methyl)-4- morpholinothieno[3,2-d]pyrimidine; treats cancer mediated by pik3 kinase; enzyme inhibitors
03/26/2008EP1902026A2 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm)
03/26/2008EP1725567B1 Spirocyclic cyclohexane derivatives with affinity to the orl-1 receptor
03/26/2008EP1556362B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
03/26/2008EP1467997B1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
03/26/2008EP1003750B1 Methods of preparing and purifying 9-nitro-20-camptothecin
03/26/2008CN101151250A Processes for preparing morphinans and intermediates thereof
03/26/2008CN101151031A Tricyclic cytoprotective compounds
03/26/2008CN100376583C Esters in position 20 of camptothecins
03/26/2008CN100376582C Process for preparing hexahydro furyl [3,2-c] quinoline derivatives
03/26/2008CN100376581C [1,4]diazocino [7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents
03/26/2008CN100376569C Inhibitors of farnesyl protein transferase
03/26/2008CN100376557C Quinoline derivatives as ligands for the neuropeptide y receptor
03/25/2008US7348457 N-[9-hydroxy-10-oxo-12(Z),15(Z)-eicosadienoyl]-L-isoleucine; for providing flower bud promoting activity, stress-resistance, antiaging activity to the plants
03/25/2008US7348328 MCH antagonists for the treatment of obesity
03/20/2008WO2008032702A1 Fluoroboron compound having aromatic ring or salt thereof, and process for production of compound having cyclic ether-fused aromatic ring by using the same
03/20/2008WO2006094187A3 Phthalazine, aza- and diaza-phthalazine compounds and methods of use
03/20/2008US20080071086 Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones
03/20/2008US20080071083 Methods for minimizing thioamide impurities
03/20/2008US20080071070 Reagents Useful for Synthesizing Rhodamine-Labeled Oligonucleotides
03/20/2008US20080070969 [3.2.0] heterocyclic compounds and methods of using the same
03/20/2008US20080070911 Ion channel modulating compounds and uses thereof
03/20/2008US20080070895 Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase
03/20/2008DE102006039912A1 Substituierte Spirotetronsäuren und ihre Verwendung Substituted Spirotetronsäuren and their use
03/20/2008CA2662920A1 Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
03/19/2008EP1900740A1 Process for producing tricyclic ketone
03/19/2008EP1900732A1 Novel nitrogenated heterocyclic compound and salt thereof
03/19/2008EP1899303A1 Novel 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/19/2008EP1636223B1 Benzothiazole derivatives as adenosine receptor ligands
03/19/2008EP1532132B1 Novel benzodioxoles
03/19/2008EP1530573B1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
03/19/2008EP1432715B1 Pyrimidine derivatives
03/19/2008CN101146889A Luminous compound containing lanthanide ion
03/19/2008CN101146808A Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
03/19/2008CN101146807A Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-C][1,5]naphthyridin-4-amine
03/19/2008CN101146798A Novel heterocyclic benzo[C]chromene derivatives useful as modulators of the estrogen receptors
03/19/2008CN101143869A Aldose reductase inhibitor structure and synthesis method thereof
03/19/2008CN101143868A Aldose reductase inhibitor structure and use
03/19/2008CN101143867A Antidepressant indolealkyl derivatves of heterocyclefused benzodioxan methylamines
03/19/2008CN100375746C Process for preparing decumbent corydalis tuber total alkaloid and its preparation and quality detecting method
03/18/2008USRE40156 Methods for repairing damaged intervertebral discs
03/18/2008US7345079 Treatment of disorder related to low cyclic GMP levels
03/18/2008US7345056 Bridged N-cyclic sulfonamido inhibitors of gamma secretase
03/18/2008US7345055 2,7-dimethylimidazo[1,2- alpha ]pyridin-3-ylmethyl)-dimethylamine; nitric oxide synthase inhibitor; neurodegenerative diseases and antiinflammatory, antitumor agent; multiple sclerosis, Parkinson's, Alzheimer's or Huntington's disease, cerebral ischemia, diabetes, meningitis, angiogenesis,
03/18/2008US7345052 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
03/18/2008US7345051 For controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases including asthma and chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic respiratory infections
03/18/2008US7344701 For conjugation with biomolecules, drugs, and toxins
03/18/2008CA2394120C Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it
03/13/2008US20080064736 Safe for plant and seed application
03/12/2008EP1896481A2 Heterocyclic spiro-compounds as aldosterone synthase inhibitors
03/12/2008EP1896480A1 Cripowellins and synthetic derivatives thereof used as medicaments
03/12/2008EP1896479A1 Alpha-(aryl-or heteroaryl-methyl)-beta-piperidinopropanoic acid compounds as orl1-receptor antagonists
03/12/2008EP1896421A2 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
03/12/2008CN101142220A Isolation of galanthamine from biological material
03/12/2008CN101142191A Process for the preparation of 10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide
03/12/2008CN100374435C Substd. pyridines and pyridazines with angiogenesis inhibiting activity
03/12/2008CN100374115C Substituted diketopiperazines as oxytocin antagonists
03/11/2008US7342112 Photochromic compounds
03/11/2008US7342035 Process for preparing zolmitriptan compounds
03/11/2008US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
03/11/2008US7342025 Substituted C-imidazo[1,2-a]pyridin-3-yl-methylamines
03/11/2008US7342011 Rifamycin analogs and uses thereof
03/11/2008US7341700 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching
03/06/2008WO2008005308A3 Compositions and methods of making a chlorin e6 derivative as a photoactive agent
03/06/2008US20080058525 Novel dye complexes and use thereof in imaging members and methods
03/06/2008US20080058524 Novel dyes and use thereof in thermal imaging members and methods
03/06/2008US20080058325 Compounds, methods and pharmaceutical compositions for inhibiting parp
03/06/2008CA2662285A1 Raf inhibitor compounds and methods of use thereof
03/05/2008EP1893617A1 Tricyclic compounds useful as serotonin inhibitors and 5-ht1a agonists and antagonists
03/05/2008EP1893599A1 Compounds for the treatment of multi-drug resistant bacterial infections
03/05/2008CN101137361A Potassium channel opener having benzofuroindole skeleton
03/05/2008CN100372855C 7-imino derivatives of camptothecin having antitumor activity
03/05/2008CN100372854C Method for preparing topotecan from 10-hydroxy-4-(S)-camptothecine
03/05/2008CN100372845C Polycyclic compounds as potent alpha2-adrenoceptor antagonists
03/05/2008CN100372844C 2-imidazo-benzothiazoles as adenosine receptor ligands
03/04/2008US7338973 7-benzyloxy-3-methoxy-10H-benzo[4,5]furo[3,2-b]indole; postmenopausal syndrome; side effect reduction; selectivity; hot flashes, vaginal dryness, endometriosis, hormone sensitive cancers, contraceptives
03/04/2008US7338964 2-(2-oxa-3-azabicyclo[2.2.2]oct-5-en-3-yl)-6-amino-9-methyl-1-deazapurine; antiinflammatory, neuroleptic agent, antiallergens, neuroprotectant and antidepressant, cognition activator; improved bioavailability, without a ribose moiety; prodrugs with primary or secondary amino or hydroxy groups
03/04/2008US7338962 Spirocyclic heterocyclic derivatives and methods of their use
03/04/2008US7338720 Organic electroluminescent element
02/2008
02/28/2008WO2008024725A1 Aza-benzofuranyl compounds and methods of use
02/28/2008WO2008022725A1 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral disorders
02/28/2008WO2008009700A8 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones